Defining Trajectories of Response in Psoriasis Patients Treated with Biologic Therapies

CONCLUSION: These subgroups, defined by change in disease over time, may be indicative of distinct endotypes driven by different biological mechanisms and may help inform the management of patients with psoriasis. Future work will aim to further delineate these mechanisms by extensively characterising the subgroups with additional molecular and pharmacological data.PMID:33829489 | DOI:10.1111/bjd.20140

Source: The British Journal of Dermatology - April 8, 2021 Category: Dermatology Authors: N Geifman N Azadbakht J Zeng T Wilkinson N Dand I Buchan D Stocken P Di Meglio R B Warren J N Barker N J Reynolds M R Barnes C H Smith C E M Griffiths N Peek BADBIR Study Group, on behalf of the PSORT Consortium Source Type: research